NTNorio Takahashi

Norio Takahashi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Norio Takahashi has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Masanori Yoshida

    First Department of Internal Medicine (M.M., E.Y., A.N., N.M., M.Y., M.A., Y.O., H.S), Nagoya University School of Medicine, Nagoya 466-8550, Japan

    2 shared publications
  • Yutaka Oiso

    First Department of Internal Medicine (S.K., T.M., H.A., H.Y., Y.M., Y.O.), Nagoya University School of Medicine, Showa-ku, Nagoya 466-8550, Japan

    2 shared publications
  • Harumi Ueda

    Department of Endocrinology and Diabetes, Nagoya Ekisaikai Hospital, Nagoya, Japan

    1 shared publication
  • Kazuki Fukuoka

    Department of Endocrinology and Diabetes, Nagoya Ekisaikai Hospital, Nakagawawa-ku, Japan

    1 shared publication
  • Miho Murakami

    Department of Endocrinology and Diabetes, Nagoya Ekisaikai Hospital, Nagoya, Japan

    1 shared publication
  • Misaki Miyata

    Department of Endocrinology and Diabetes, Nagoya Ekisaikai Hospital, Nagoya, Japan

    1 shared publication

Latest Publications

  • Open Access

    A novel loss-of-function mutation of GATA3 (p.R299Q) in a Japanese family with Hypoparathyroidism, Deafness, and Renal Dysplasia (HDR) syndrome

    by Tetsuji Okawa, Masanori Yoshida, Takeshi Usui, Takahiro Kudou, Yasumasa Iwasaki, Kazuki Fukuoka, Norio Takahashi, Yuka Uehara, Yutaka Oiso

    Hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome is a rare autosomal dominant disorder caused by mutations in the zinc finger transcription factor gene, GATA3. GATA3 has 2 zinc finger domains, which play an important role in the increase in target gene transcription activity. A 50-year-old woman and her 27-year-old daughter were followed up because of hypoparathyroidism. They had bilateral sensorineural deafness. Abdominal computed tomography scanning revealed renal dysplasia in the mother, but no renal anomaly in the daughter. Direct sequencing of GATA3 gene revealed a novel heterozygous missense mutation at codon 299 (p.R299Q) in exon 4. This mutation is located at the junction between the 2 zinc fingers. The structure prediction showed that it caused a conformation change in this junction area, affecting the spatial position of the zinc fingers. Additionally, a more marked conformation change was observed in the N-terminal zinc finger region compared to that in the C-terminal region. Functional analysis of this mutant protein using an in vitro luciferase reporter assay system confirmed that the mutation abolished the enhancing effects of wild-type GATA3 on the promoter activity of the consensus GATA responsive element and that of human PTH gene. We identified a novel R299Q mutation in GATA3 in a Japanese family with HDR syndrome. We confirmed that R299Q is a loss-of-function mutation, due to the extensive conformational change in the zinc fingers of GATA3.


    • 1 January 2014
      • Vol. 35  (5) , 342-6

    An unusual case of hypopituitarism and transient thyrotoxicosis following asymptomatic pituitary apoplexy.

    by Masanori Yoshida, Miho Murakami, Harumi Ueda, Misaki Miyata, Norio Takahashi, Yutaka Oiso

    Although pituitary function is often impaired in pituitary apoplexy, the development of thyrotoxicosis is rare. We describe an unusual case of hypopituitarism due to pituitary apoplexy coexisting with transient hyperthyroidism. A 74-year-old woman presented with severe fatigue, palpitation, appetite loss, hypotension, and hyponatremia. Endocrine studies showed hyperthyroidism and anterior pituitary hormone deficiencies. A magnetic resonance imaging suggested recent-onset pituitary apoplexy in a pituitary tumor, although the patient had no apoplectic symptoms such as headache and visual disturbance. Thyrotoxicosis and adrenal insufficiency worsened her general condition. Glucocorticoid supplementation improved her clinical symptoms and hyponatremia. Serum anti-thyrotropin receptor and thyroid-stimulating antibody titers were negative, and her thyroid function was spontaneously normalized without antithyroid medication, suggesting painless thyroiditis. Thereafter, her thyroid function decreased because of central hypothyroidism and 75 µg of levothyroxine was needed to maintain thyroid function at the euthyroid stage. The pituitary mass was surgically removed and an old hematoma was detected in the specimen. Considering that painless thyroiditis develops as a result of an autoimmune process, an immune rebound mechanism due to adrenal insufficiency probably caused painless thyroiditis. Although the most common type of thyroid disorder in pituitary apoplexy is central hypothyroidism, thyrotoxicosis caused by painless thyroiditis should be considered even if the patient has pituitary deficiencies. Because thyrotoxicosis with adrenal insufficiency poses a high risk for a life-threatening adrenal crisis, prompt diagnosis and treatment are critical.